Filing Flows › Comparisons › DCTH vs ANIK
Delcath Systems vs Anika Therapeutics: DCTH and ANIK compared
Delcath Systems is the larger company: $35.1M of revenue in its latest quarter (Q3 2026) against $30.6M for Anika Therapeutics (Q3 2026). Delcath Systems is growing faster (+71% against +10% a year earlier). Delcath Systems is more profitable, with an operating margin of 20.3% against -2.3%.
Where the money goes: DCTH and ANIK
Delcath Systems (DCTH) · Q3 2026
Delcath Systems, Q3 2026: revenue $35.1M (+71% year over year), operating margin 20.3%, net earnings $7.0M, operating cash flow $8.2M. The chart follows the revenue to costs, profit and cash.
Anika Therapeutics (ANIK) · Q3 2026
Anika Therapeutics, Q3 2026: revenue $30.6M (+10% year over year), operating margin -2.3%, net loss $311K, operating cash flow $8.4M. The chart follows the revenue to costs, profit and cash.
| Delcath Systems (DCTH) | Anika Therapeutics (ANIK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $35.1M | $30.6M |
| Revenue growth, Y/Y | +71% | +10% |
| Gross margin | 88.8% | — |
| Operating margin | 20.3% | -2.3% |
| Net earnings | $7.0M | −$311K |
| Net margin | 19.8% | -1.0% |
| Operating cash flow | $8.2M | $8.4M |
| Free cash flow | $6.9M | $6.7M |
Where the revenue comes from
Delcath Systems
- HEPZATO KIT: $32.7M (93%)
- CHEMOSAT: $2.4M (7%)
Anika Therapeutics
- OEM Channel: $16.6M (54%)
- Commercial Channel: $14.0M (46%)
Questions
Which is bigger, Delcath Systems or Anika Therapeutics?
Delcath Systems is the larger company: $35.1M of revenue in its latest quarter (Q3 2026) against $30.6M for Anika Therapeutics (Q3 2026).
Is Delcath Systems or Anika Therapeutics growing faster?
Delcath Systems is growing faster (+71% against +10% a year earlier).
Which is more profitable, Delcath Systems or Anika Therapeutics?
Delcath Systems is more profitable, with an operating margin of 20.3% against -2.3%.
More: Delcath Systems earnings · how Delcath Systems makes money · Anika Therapeutics earnings · how Anika Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.